Envoy Medical, Inc. is a hearing health company. The Company is engaged in providing medical technologies across the hearing loss spectrum, all designed to shift the paradigm within the hearing industry and bring both providers and patients the hearing devices they require. Its hearing solutions include hearing aids, middle ear implants, bone conduction devices and cochlear implants. The bone conduction hearing device has two components: an external component and a surgically implanted fixture placed in the bone behind the ear. Its bone conduction hearing device offers amplification without ear mold in the ear. Its hearing aids are devices that amplify sound for those with mild to moderate hearing loss. Its Esteem is a fully implanted active middle ear implant designed to improve the hearing of adults diagnosed with moderate to severe sensorineural hearing loss. Cochlear implants are a solution for people with moderate-to-profound sensorineural hearing loss.
成長中
同社は成長フェーズにあり、最新の年間収益はUSD 225.00Kに達しています。
高い利益成長
同社の純利益は業界をリードしており、最新の年間純利益はUSD 225.00Kです。
割高
同社の最新のPEは-0.51で、過去3年間の水準と比較して高値圏にあります。
機関投資家の買い増し
最新の機関投資家の保有株数は12.73M株で、前四半期比で40.22%増加しています。
バンガードが保有
スター投資家バンガードは本銘柄を394.96K株保有しています。
市場活動が活発
同社への投資家の関心が高まっており、20日間の売買回転率は3.14です。